A retrospective study to investigate the prevalence and describe the clinicopathological characteristics, treatments, and outcomes of HER2-low Breast Cancer in Taiwan
This study suggested that two-thirds of HER2-negative unresectable/mBC patients in Taiwan were HER2-low. Reassessing the HER2 status of HER2-negative patients could improve treatment strategies with the evolving HER2 classification paradigm.
Authors
- Jiun‐I Lai (ORCID: https://orcid.org/0000-0002-8233-5466)
- Yen‐Shen Lu (ORCID: https://orcid.org/0000-0001-7461-1291)
- Ta‐Chung Chao (ORCID: https://orcid.org/0000-0003-1451-1939)
- Chih‐Yi Hsu (ORCID: https://orcid.org/0000-0002-1667-4291)
- Kuo-Ting Lee (ORCID: https://orcid.org/0000-0001-8651-523X)
- Yu-Ciou Lin
- Ling‐Ming Tseng (ORCID: https://orcid.org/0000-0002-4648-6646)
- Wei-Chen Yang
- Chun‐Yu Liu (ORCID: https://orcid.org/0000-0003-2336-4731)
- Yi‐Hsuan Lee (ORCID: https://orcid.org/0000-0001-6279-6006)
- Chi‐Cheng Huang (ORCID: https://orcid.org/0000-0003-4378-4776)
- Ching‐Ya Huang (ORCID: https://orcid.org/0000-0003-1214-6587)
- Huiwen Chen (ORCID: https://orcid.org/0000-0001-9802-2782)
- Yu‐Ting Huang (ORCID: https://orcid.org/0000-0002-7451-0690)
- Yi‐Fang Tsai (ORCID: https://orcid.org/0000-0001-7665-0462)
- Po-Hsiang Huang
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Taiwan University (TW)
- National Taipei University of Nursing and Health Science (TW)
- Taipei Veterans General Hospital (TW)
- National Taiwan University Hospital (TW)
- National Cheng Kung University Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Cancer Treatment and Research Communications
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ctarc.2025.100893
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00